Optimization of plasmepsin inhibitor by focusing on similar structural feature with chloroquine to avoid drug-resistant mechanism of Plasmodium falciparum

Takuya Miura, Koushi Hidaka, Yukiko Azai, Keisuke Kashimoto, Yuko Kawasaki, Shen En Chen, Renato Ferreira De Freitas, Ernesto I Freire, Yoshiaki Kiso

Research output: Contribution to journalArticle

Abstract

The plasmepsins are specific aspartic proteases of the malaria parasite and a potential target for developing new antimalarial agents. Our previously reported peptidomimetic plasmepsin inhibitor with modified 2-aminoethylamino substituent, KNI-10740, was tested against chloroquine sensitive Plasmodium falciparum, D6, to be highly potent, however, the inhibitor exhibited about 5 times less activity against multi-drug resistant parasite (TM91C235). We hypothesized the potency reduction resulted from structural similarity between 2-aminoethylamino substituent of KNI-10740 and chloroquine. Then, we modified the moiety and finally identified compound 15d (KNI-10823), that could avoid drug-resistant mechanism of TM91C235 strain.

Original languageEnglish (US)
Pages (from-to)1698-1701
Number of pages4
JournalBioorganic and Medicinal Chemistry Letters
Volume24
Issue number7
DOIs
StatePublished - Apr 1 2014

Fingerprint

Chloroquine
Plasmodium falciparum
Parasites
Peptidomimetics
Antimalarials
Pharmaceutical Preparations
Malaria
Peptide Hydrolases
plasmepsin

Keywords

  • Allophenylnorstatine
  • Antimalarial drug
  • Aspartic protease
  • Drug-resistance
  • Plasmepsin inhibitor

ASJC Scopus subject areas

  • Biochemistry
  • Clinical Biochemistry
  • Molecular Biology
  • Molecular Medicine
  • Organic Chemistry
  • Drug Discovery
  • Pharmaceutical Science
  • Medicine(all)

Cite this

Optimization of plasmepsin inhibitor by focusing on similar structural feature with chloroquine to avoid drug-resistant mechanism of Plasmodium falciparum. / Miura, Takuya; Hidaka, Koushi; Azai, Yukiko; Kashimoto, Keisuke; Kawasaki, Yuko; Chen, Shen En; De Freitas, Renato Ferreira; Freire, Ernesto I; Kiso, Yoshiaki.

In: Bioorganic and Medicinal Chemistry Letters, Vol. 24, No. 7, 01.04.2014, p. 1698-1701.

Research output: Contribution to journalArticle

Miura, Takuya ; Hidaka, Koushi ; Azai, Yukiko ; Kashimoto, Keisuke ; Kawasaki, Yuko ; Chen, Shen En ; De Freitas, Renato Ferreira ; Freire, Ernesto I ; Kiso, Yoshiaki. / Optimization of plasmepsin inhibitor by focusing on similar structural feature with chloroquine to avoid drug-resistant mechanism of Plasmodium falciparum. In: Bioorganic and Medicinal Chemistry Letters. 2014 ; Vol. 24, No. 7. pp. 1698-1701.
@article{b8a60114abdd4147b8e15494505b273d,
title = "Optimization of plasmepsin inhibitor by focusing on similar structural feature with chloroquine to avoid drug-resistant mechanism of Plasmodium falciparum",
abstract = "The plasmepsins are specific aspartic proteases of the malaria parasite and a potential target for developing new antimalarial agents. Our previously reported peptidomimetic plasmepsin inhibitor with modified 2-aminoethylamino substituent, KNI-10740, was tested against chloroquine sensitive Plasmodium falciparum, D6, to be highly potent, however, the inhibitor exhibited about 5 times less activity against multi-drug resistant parasite (TM91C235). We hypothesized the potency reduction resulted from structural similarity between 2-aminoethylamino substituent of KNI-10740 and chloroquine. Then, we modified the moiety and finally identified compound 15d (KNI-10823), that could avoid drug-resistant mechanism of TM91C235 strain.",
keywords = "Allophenylnorstatine, Antimalarial drug, Aspartic protease, Drug-resistance, Plasmepsin inhibitor",
author = "Takuya Miura and Koushi Hidaka and Yukiko Azai and Keisuke Kashimoto and Yuko Kawasaki and Chen, {Shen En} and {De Freitas}, {Renato Ferreira} and Freire, {Ernesto I} and Yoshiaki Kiso",
year = "2014",
month = "4",
day = "1",
doi = "10.1016/j.bmcl.2014.02.051",
language = "English (US)",
volume = "24",
pages = "1698--1701",
journal = "Bioorganic and Medicinal Chemistry Letters",
issn = "0960-894X",
publisher = "Elsevier Limited",
number = "7",

}

TY - JOUR

T1 - Optimization of plasmepsin inhibitor by focusing on similar structural feature with chloroquine to avoid drug-resistant mechanism of Plasmodium falciparum

AU - Miura, Takuya

AU - Hidaka, Koushi

AU - Azai, Yukiko

AU - Kashimoto, Keisuke

AU - Kawasaki, Yuko

AU - Chen, Shen En

AU - De Freitas, Renato Ferreira

AU - Freire, Ernesto I

AU - Kiso, Yoshiaki

PY - 2014/4/1

Y1 - 2014/4/1

N2 - The plasmepsins are specific aspartic proteases of the malaria parasite and a potential target for developing new antimalarial agents. Our previously reported peptidomimetic plasmepsin inhibitor with modified 2-aminoethylamino substituent, KNI-10740, was tested against chloroquine sensitive Plasmodium falciparum, D6, to be highly potent, however, the inhibitor exhibited about 5 times less activity against multi-drug resistant parasite (TM91C235). We hypothesized the potency reduction resulted from structural similarity between 2-aminoethylamino substituent of KNI-10740 and chloroquine. Then, we modified the moiety and finally identified compound 15d (KNI-10823), that could avoid drug-resistant mechanism of TM91C235 strain.

AB - The plasmepsins are specific aspartic proteases of the malaria parasite and a potential target for developing new antimalarial agents. Our previously reported peptidomimetic plasmepsin inhibitor with modified 2-aminoethylamino substituent, KNI-10740, was tested against chloroquine sensitive Plasmodium falciparum, D6, to be highly potent, however, the inhibitor exhibited about 5 times less activity against multi-drug resistant parasite (TM91C235). We hypothesized the potency reduction resulted from structural similarity between 2-aminoethylamino substituent of KNI-10740 and chloroquine. Then, we modified the moiety and finally identified compound 15d (KNI-10823), that could avoid drug-resistant mechanism of TM91C235 strain.

KW - Allophenylnorstatine

KW - Antimalarial drug

KW - Aspartic protease

KW - Drug-resistance

KW - Plasmepsin inhibitor

UR - http://www.scopus.com/inward/record.url?scp=84897457641&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84897457641&partnerID=8YFLogxK

U2 - 10.1016/j.bmcl.2014.02.051

DO - 10.1016/j.bmcl.2014.02.051

M3 - Article

VL - 24

SP - 1698

EP - 1701

JO - Bioorganic and Medicinal Chemistry Letters

JF - Bioorganic and Medicinal Chemistry Letters

SN - 0960-894X

IS - 7

ER -